Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 2,708,000 | 2,659,000 | 2,003,000 | 2,543,000 | 2,904,000 |
| Cost of Goods | 999,000 | 869,000 | 791,000 | 806,000 | 851,000 |
| Gross Profit | 1,709,000 | 1,790,000 | 1,212,000 | 1,737,000 | 2,054,000 |
| Operating Expenses | 1,658,000 | 1,996,000 | 1,282,000 | 1,591,000 | 1,844,000 |
| Operating Income | 50,000 | -205,000 | -71,000 | 146,000 | 210,000 |
| Interest Expense | 96,000 | 86,000 | 91,000 | 88,000 | 180,000 |
| Other Income | 353,000 | 64,000 | -19,000 | -36,000 | -36,000 |
| Pre-tax Income | 307,000 | -227,000 | -181,000 | 22,000 | -6,000 |
| Income Tax | 95,000 | -72,000 | -33,000 | 12,000 | -4,002,000 |
| Net Income Continuous | 212,000 | -155,000 | -148,000 | 10,000 | 3,996,000 |
| Net Income | $209,000 | $-155,000 | $-147,000 | $11,000 | $3,996,000 |
| EPS Basic Total Ops | 0.14 | -0.12 | -0.11 | 0.01 | 2.87 |
| EPS Basic Continuous Ops | 0.15 | -0.11 | -0.10 | 0.01 | 2.87 |
| EPS Diluted Total Ops | 0.14 | -0.12 | -0.11 | 0.01 | 2.83 |
| EPS Diluted Continuous Ops | 0.15 | -0.11 | -0.10 | 0.01 | 2.83 |
| EBITDA(a) | $421,000 | $265,000 | $284,000 | $607,000 | $209,000 |